Naresh Dugal, DPM
Primary Podiatric Medicine · Scottsdale, AZNPI 1891180816
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,184 of the $3,161 with a category attached, or 69.1%. 17 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 37.8% of the total. Reporting peaked in 2023 at $1,288 and has fallen 67.9% since, to $413 in 2025.
Across 42 payments — averaging $75.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$1K
- Averitas Pharma Inc.$555
- Paratek Pharmaceuticals, Inc.$262
- Smith+Nephew$190
- Bioventus LLC$160
- Osteomed LLC$149
- plus $651 from 11 others
What the payments were for
- Travel & lodging$97731%
- Food & beverage$2,18469%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 8 | $1,194 |
| Averitas Pharma Inc. | 10 | $555 |
| Paratek Pharmaceuticals, Inc. | 3 | $262 |
| Smith+Nephew | 4 | $190 |
| Bioventus LLC | 2 | $160 |
| Osteomed LLC | 1 | $149 |
| Medtronic | 1 | $139 |
| Tenex Health Inc. | 1 | $125 |
| Amgen | 1 | $110 |
| Integra Lifesciences Corporation | 1 | $72 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $57 |
| Organogenesis Inc. | 2 | $49 |
| AbbVie | 1 | $26 |
| Fidia Pharma USA Inc. | 1 | $24 |
| Globus Medical | 1 | $19 |
| Mimedx Group, Inc. | 1 | $17 |
| Advanced Oxygen Therapy Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$886
- Qutenza$426
- NUZYRA$241
- INTELLIS ADAPTIVESTIM$139
- OsteoAMP$137
- Versajet$120
- KRYSTEXXA$110
How this compares
Too few primary podiatric medicine providers in Arizonato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 17 | $594 |
| Methylprednisolone | 19 | $146 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Scottsdale
- Ruth KosakScottsdale$333
- Warren JosephPhoenix$529K
- Zeno PfauTucson$5K
- David CorcoranPhoenix$4K
- Ronaldo HolgadoSurprise$2K
- Brian HutchesonTucson$902
- Jean KroynCottonwood$306
- Stephen GellerPhoenix$78
- Phillip TutnauerPinon$36
- Sanford KanerSurprise$20
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.